E
ENVOY MEDICAL INC.
NASDAQ: COCH (Envoy Medical, Inc.)
Last update: 14 hours ago1.37
0.06 (4.58%)
| Previous Close | 1.31 |
| Open | 1.31 |
| Volume | 6,537 |
| Avg. Volume (3M) | 25,773 |
| Market Cap | 29,172,644 |
| Price / Sales | 92.98 |
| 52 Weeks Range |
| Operating Margin (TTM) | -10,771.43% |
| Diluted EPS (TTM) | -1.28 |
| Quarterly Revenue Growth (YOY) | -55.80% |
| Current Ratio (MRQ) | 1.25 |
| Operating Cash Flow (TTM) | -17.95 M |
| Levered Free Cash Flow (TTM) | -12.68 M |
| Return on Assets (TTM) | -125.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Envoy Medical, Inc. | Mixed | Bullish |
AIStockmoo Score
0.8
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.83 |
|
Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 50.15% |
| % Held by Institutions | 9.55% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Atlas Merchant Capital Llc | 31 Dec 2024 | 555,527 |
| Weiss Asset Management Lp | 31 Dec 2024 | 396,654 |
| Dsg Capital Advisors, Llc | 31 Dec 2024 | 163,642 |
| Lake Street Advisors Group, Llc | 31 Dec 2024 | 45,455 |
| Highpoint Advisor Group Llc | 31 Dec 2024 | 38,662 |
| Bluestem Wealth Partners, Llc | 31 Dec 2024 | 10,454 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 31 Mar 2025 | Announcement | Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results |
| 17 Mar 2025 | Announcement | Hearing Device Coverage Clarification Act Reintroduced in House and Senate |
| 12 Mar 2025 | Announcement | Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device |
| 10 Mar 2025 | Announcement | Envoy Medical to Participate in the 37th Annual ROTH Conference |
| 24 Feb 2025 | Announcement | First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant |
| 14 Feb 2025 | Announcement | Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |